Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Ziauddin University
A total of 58 participants will be recruited for this study after obtaining informed voluntary assent from the guardians. Simple random sampling using the envelop method will be used for the group allocation, to which the participants will be blind. Each participant will be allocated randomly to the treatment group (n=29) that will receive Simulated Equestrian Therapy and the control group (n=29) to receive Neuromotor Therapy. Each participant will be assessed at baseline, after 6 and 12 weeks of intervention using Bruinink's test of motor proficiency (BOT-2) and 10 meter walk test (10MWT). Each participant's blood pressure and heart rate will also be recorded before each session to ensure safety. The participants will be wearing protective gear (belt, helmet, knee and elbow pads) and portable telemetry during the entire session. The session duration in both groups will comprise 30-45 minutes on average, varying with the progression each week. Each session will be provided three times/a week for 3 months.
Age
6–12
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
Individuals with diagnosed DS are referred by a physician.
Age 6-12 years.
Ability to independently walk, GMFCS level-I.
You may not be if
Diagnosed atlantoaxial instability.
Diagnosed osteoarticular, pulmonary or cardiovascular disorders.
Diagnosed severe behavioral or cognitive impairment.
Severe visual impairment that cannot be corrected with glasses.
If equestrian therapy received in the last 1-year.
Refusal of parents/guardians to participate in the study.